Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society - 1 Jan 2011

Lee Jee-Young, Cho Jinwhan, Lee Eun-Kyung, Park Sung-Sup, Jeon Beom S

Abstract excerpt

To examine whether there is a differential genetic susceptibility in the diphasic and peak-dose forms of levodopa-induced dyskinesias (LID) in patients with Parkinson's disease (PD). The study cohort comprised 503 unrelated Korean PD patients who were treated with levodopa and had a disease durat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Dyskinesia, Drug-Induced
Share to Levodopa

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Parkinson Disease

Share to Probability

Share to Receptors, Dopamine D2

Share to Receptors, N-Methyl-D-Aspartate

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 20945430
DOI: 10.1002/mds.23400

Genes

DRD3
DRD2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20945430-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.PMID 20945430Read ↗

Dopamine pathway and Parkinson’s risk variants are associated with levodopa-induced dyskinesiaSemantic proximity Read ↗

Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.Semantic proximity Read ↗

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.Semantic proximity Read ↗

Levodopa-induced dyskinesia in early-onset Parkinson's disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand.Semantic proximity Read ↗

Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.Semantic proximity Read ↗

Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.Semantic proximity Read ↗

Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.Semantic proximity Read ↗

GAK rs1564282 and DGKQ rs11248060 increase the risk for Parkinson's disease in a Chinese population.Semantic proximity Read ↗

Associations between variants in levodopa metabolic pathway genes and levodopa-induced dyskinesia in Parkinson's disease.Semantic proximity Read ↗

Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.Semantic proximity Read ↗

Analysis of the genotype of diacylglycerol kinase delta single-nucleotide polymorphisms in Parkinson disease in the Han Chinese population.Semantic proximity Read ↗

Early motor response to dopamine replacement therapy in Parkinson's disease patients carrying GBA variants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.